An Add-On Treatment for Moderate COPD with Squill-Oxymel (a Traditional Formulation from Drimia maritima (L.) Stearn): A Pilot Randomized Triple-Blinded Placebo-Controlled Clinical Trial

Table 5

Comparison of the mean score of total and dimensions of St. George’s questionnaire between Squill-Oxymel and placebo groups.

Variables	Group	Before M ± S—	After M ± S—	paired t-test
St. George symptom score	Squill-Oxymel; Placebo	61.19 ± 22.97691; 42.64 ± 20.54949	56.53 ± 25.04019; 36.69 ± 16.84810	0.24; 0.01
St. George's activity score	Squill-Oxymel; Placebo	61.77 ± 22.31835; 53.97 ± 24.42456	59.52 ± 22.17675; 55.59 ± 26.01322	0.22; 0.41
St. George’s impact score	Squill-Oxymel; Placebo	39.06 ± 24.44876; 33.05 ± 22.87777	38.89 ± 24.31328; 31.96 ± 24.34633	0.95; 0.66
St. George’s total score	Squill-Oxymel; Placebo	49.65 ± 21.43897; 41.01 ± 21.20870	48.21 ± 21.92016; 40.00 ± 22.03344	0.55; 0.50

M ± SD: mean ± standard deviation.